"We showed people with Alzheimer's disease have more gut inflammation," University of Wisconsin psychologist Barbara Bendlin ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

After some time, early symptomatic Alzheimer's disease begins with a small amount of memory loss and confusion that can be ...

NICE has said it expects to evaluate dozens of potential treatments for Alzheimer’s disease over the next few years. Elisabeth Mahase examines what we know about these drugs This year the National ...

Some researchers seek to establish a single abnormal result on a set of biomarker-based tests as sufficient to diagnose the ...

A new therapy may delay Alzheimer's disease progression by years, according to a study by researchers at Texas A&M University ...

Diagnosis of Alzheimer's disease (AD) is currently largely based on the presence of biomarkers. This may lead to a ...

Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% ...

The National Institutes of Health reports that incidences of Alzheimer's disease and other dementia increased by roughly 148 ...

Today, Prof. Howard Feldman presented revised diagnostic criteria for Alzheimer's disease at the Clinical Trials on Alzheimer's Disease (CTAD) Conference in Madrid on behalf of the International ...

Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking ...

They discovered that patients who were prescribed semaglutide (the active ingredient in Ozempic and Wegovy) had a "significantly" lower risk of developing Alzheimer’s disease compared to people who ...